Woebot é avaliado como Chatbot terapêutico com IA. Esta página segue a estrutura da análise em inglês e leva os mesmos critérios editoriais para uma versão localizada.
Na nossa avaliação, o uso mais adequado é: Psychiatrists and health systems looking for a patient-facing digital therapeutic to extend CBT-based support between appointments. Particularly relevant for adolescent depression, access-limitado populations, and bridging the psychiatric workforce shortage.
O principal ponto forte é woebot earns a Good rating in psychiatry as a patient-facing digital therapeutic rather than a clinician tool. Its Stanford-developed CBT approach and FDA Breakthrough Device Designation are notable, though the narrow therapeutic scope limits broader clinical utility. A limitação mais importante é patient-facing tool, not a clinical decision support platform for psychiatrists